NCT07094685 Ivonescimab Before Surgery for the Treatment of Resectable Stage II-IV Head and Neck Cancer Status RECRUITING Phase PHASE2
NCT07070479 Combination Therapy for PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma: A Bayesian Adaptive Phase II Trial Status RECRUITING Phase PHASE2
NCT07070466 Ivonescimab in Comb. With FOLFOX in Advanced HER2 Neg. GEA Status RECRUITING Phase PHASE2
NCT07038915 STRIVE: A Single-arm Phase 2 Study on Treatment of Lung Squamous Cell Carcinoma by Tiragolumab Plus Ivonescimab for Patients Who Progressed on Platinum Doublets and Anti-PD-1/PD-L1 Status WITHDRAWN Phase PHASE2
NCT07017673 Phase II Trial of Ivonescimab in Combination With Carboplatin + Docetaxel in Patients With Early-Stage Triple Negative Breast Cancer Status RECRUITING Phase PHASE2
NCT06977542 Neoadjuvant Therapy With Ivonescimab Combined With Chemotherapy for Triple-Negative Breast Cancer Status NOT_YET_RECRUITING Phase PHASE2
NCT06959550 Phase II Study of Anti-PD-1/VEGF Bispecific Antibody Ivonescimab in Patients With Previously Treated Metastatic Colorectal Cancer Status RECRUITING Phase PHASE2
NCT06951646 ctDNA-MRD Guided Escalation of Ivonescimab and Docetaxel in Advanced NSCLC With Long-Term Responses to First-line Immunotherapy (CR1STAL-Adaptive) Status RECRUITING Phase PHASE2
NCT06940518 Phase II Trial of Ivonescimab in Previously Treated Patients With Advanced Clear Cell Renal Cell Carcinoma Status RECRUITING Phase PHASE2
NCT06925724 A Study of Ivonescimab in People With Endometrial and Cervical Cancers Status RECRUITING Phase PHASE2
NCT06877650 First-in-Human Investigation of JMT108 Injection in Participants With Advanced Malignant Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT06868732 Evaluation of JSKN016 Combination Therapy in Subjects With NSCLC Status RECRUITING Phase PHASE1
NCT06846346 Testing Ivonescimab in Combination With Chemotherapy in Advanced or Metastatic Gastric/Gastroesophageal Adenocarcinoma Status RECRUITING Phase PHASE2
NCT06844422 Adapted Guided Stereotactic Body Radiotherapy Combined With Chemotherapy and Enhancement of Novel Drug Ivonescimab for Pancreatic Cancer (ASCEND) Status RECRUITING Phase PHASE1/PHASE2
NCT06840834 Evaluating Ivonescimab as a Potential Treatment for Pleural Mesothelioma Patients Whose Cancer Has Returned After Previous Immunotherapy and Chemotherapy Status RECRUITING Phase PHASE2
NCT06814067 Phase II Multi-centered Study of Perioperative Ivonescimab Versus Pembrolizumab Combined with Standard of Care (SOC) in Patients with Resectable, Locally Advanced Head and Neck Squamous Cell Carcinoma Status NOT_YET_RECRUITING Phase PHASE2
NCT06805617 A Phase 2 Trial of Ivonescimab for Patients With Advanced, Metastatic Salivary Gland Cancers Status RECRUITING Phase PHASE2
NCT06802666 Short-course Radiotherapy Followed by AK112 and CAPOX as Neoadjuvant Therapy for Locally Advanced Rectal Cancer Status RECRUITING Phase PHASE2